Your browser doesn't support javascript.
loading
L74V increases the reverse transcriptase content of HIV-1 virions with non-nucleoside reverse transcriptase drug-resistant mutations L100I+K103N and K101E+G190S, which results in increased fitness.
Wang, Jiong; Li, Dongge; Bambara, Robert A; Yang, Hongmei; Dykes, Carrie.
Afiliación
  • Wang J; Department of Medicine, University of Rochester Medical Center, Rochester, NY 14642, USA.
  • Li D; Department of Medicine, University of Rochester Medical Center, Rochester, NY 14642, USA.
  • Bambara RA; Department of Microbiology and Immunology, University of Rochester Medical Center, Rochester, NY 14642, USA.
  • Yang H; Department of Biostatistics and Computational Biology, University of Rochester Medical Center, Rochester, NY 14642, USA.
  • Dykes C; Department of Medicine, University of Rochester Medical Center, Rochester, NY 14642, USA.
J Gen Virol ; 94(Pt 7): 1597-1607, 2013 Jul.
Article en En | MEDLINE | ID: mdl-23535575
The fitness of non-nucleoside reverse transcriptase inhibitor (NNRTI) drug-resistant reverse transcriptase (RT) mutants of HIV-1 correlates with the amount of RT in the virions and the RNase H activity of the RT. We wanted to understand the mechanism by which secondary NNRTI-resistance mutations, L100I and K101E, and the nucleoside resistance mutation, L74V, alter the fitness of K103N and G190S viruses. We measured the amount of RT in virions and the polymerization and RNase H activities of mutant RTs compared to wild-type, K103N and G190S. We found that L100I, K101E and L74V did not change the polymerization or RNase H activities of K103N or G190S RTs. However, L100I and K101E reduced the amount of RT in the virions and subsequent addition of L74V restored RT levels back to those of G190S or K103N alone. We conclude that fitness changes caused by L100I, K101E and L74V derive from their effects on RT content.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Virión / Replicación Viral / VIH-1 / Inhibidores de la Transcriptasa Inversa / Fármacos Anti-VIH / Farmacorresistencia Viral / Transcriptasa Inversa del VIH / Mutación Límite: Humans Idioma: En Revista: J Gen Virol Año: 2013 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Virión / Replicación Viral / VIH-1 / Inhibidores de la Transcriptasa Inversa / Fármacos Anti-VIH / Farmacorresistencia Viral / Transcriptasa Inversa del VIH / Mutación Límite: Humans Idioma: En Revista: J Gen Virol Año: 2013 Tipo del documento: Article País de afiliación: Estados Unidos